These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 17002262)

  • 1. Drug evaluation: AMG-531 for the treatment of thrombocytopenias.
    Rice L
    Curr Opin Investig Drugs; 2006 Sep; 7(9):834-41. PubMed ID: 17002262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMG 531: an investigational thrombopoiesis-stimulating peptibody.
    Nichol JL
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):723-5. PubMed ID: 16933266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes.
    Tiu RV; Sekeres MA
    Expert Opin Biol Ther; 2008 Jul; 8(7):1021-30. PubMed ID: 18549331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Romiplostim.
    Cines DB; Yasothan U; Kirkpatrick P
    Nat Rev Drug Discov; 2008 Nov; 7(11):887-8. PubMed ID: 18974747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Romiplostim management of immune thrombocytopenic purpura.
    Ipema HJ; Jung MY; Lodolce AE
    Ann Pharmacother; 2009 May; 43(5):914-9. PubMed ID: 19401474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise of thrombopoietins in the treatment of ITP.
    Kuter DJ
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):464-6. PubMed ID: 16167023
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing the platelet count in chronic ITP.
    Nurden AT; Nurden P
    Lancet; 2008 Feb; 371(9610):362-4. PubMed ID: 18242396
    [No Abstract]   [Full Text] [Related]  

  • 8. An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.
    Newland A; Caulier MT; Kappers-Klunne M; Schipperus MR; Lefrere F; Zwaginga JJ; Christal J; Chen CF; Nichol JL
    Br J Haematol; 2006 Nov; 135(4):547-53. PubMed ID: 17061981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMG 531 for chronic ITP.
    Tauro S
    N Engl J Med; 2007 Jan; 356(3):307; author reply 308. PubMed ID: 17229962
    [No Abstract]   [Full Text] [Related]  

  • 10. AMG 531 for chronic ITP.
    Prasad K
    N Engl J Med; 2007 Jan; 356(3):307-8; author reply 308. PubMed ID: 17240535
    [No Abstract]   [Full Text] [Related]  

  • 11. New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura.
    Kuter DJ
    Eur J Haematol Suppl; 2008 Feb; (69):9-18. PubMed ID: 18211568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical roundtable monograph. Combination therapies for MDS.
    Scott BL
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):S13-5. PubMed ID: 19731466
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacodynamics and pharmacokinetics of AMG 531, a thrombopoiesis-stimulating peptibody, in healthy Japanese subjects: a randomized, placebo-controlled study.
    Kumagai Y; Fujita T; Ozaki M; Sahashi K; Ohkura M; Ohtsu T; Arai Y; Sonehara Y; Nichol JL
    J Clin Pharmacol; 2007 Dec; 47(12):1489-97. PubMed ID: 17925591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.
    Bussel JB; Kuter DJ; George JN; McMillan R; Aledort LM; Conklin GT; Lichtin AE; Lyons RM; Nieva J; Wasser JS; Wiznitzer I; Kelly R; Chen CF; Nichol JL
    N Engl J Med; 2006 Oct; 355(16):1672-81. PubMed ID: 17050891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapeutic options for adult chronic immune thrombocytopenic purpura: a brief review.
    Panzer S
    Vox Sang; 2008 Jan; 94(1):1-5. PubMed ID: 17973895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients.
    Bose P; Hussein KK; Terrell DR; Berger D; Rice L; George JN
    Am J Hematol; 2009 Jul; 84(7):459-61. PubMed ID: 19484732
    [No Abstract]   [Full Text] [Related]  

  • 17. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management.
    Stasi R; Evangelista ML; Stipa E; Buccisano F; Venditti A; Amadori S
    Thromb Haemost; 2008 Jan; 99(1):4-13. PubMed ID: 18217129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune thrombocytopenic purpura--the changing therapeutic landscape.
    Bromberg ME
    N Engl J Med; 2006 Oct; 355(16):1643-5. PubMed ID: 17050888
    [No Abstract]   [Full Text] [Related]  

  • 19. New insights and therapeutics for immune-mediated thrombocytopenia.
    Metjian A; Abrams CS
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):71-84. PubMed ID: 18095908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics and pharmacokinetics of AMG 531, a novel thrombopoietin receptor ligand.
    Wang B; Nichol JL; Sullivan JT
    Clin Pharmacol Ther; 2004 Dec; 76(6):628-38. PubMed ID: 15592334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.